- Hypokalemia and metabolic alkalosis
- More sodium reaches the collecting duct, where it is swapped for potassium and hydrogen ions. Management: Check electrolytes; add potassium-rich foods, supplements, or a potassium-sparing diuretic.
- Hyponatremia
- Thiazides impair urine dilution in the distal tubule. Management: Check sodium, especially in older adults; restrict water for dilutional hyponatremia.
- Hypercalcemia
- Thiazides increase calcium reabsorption in the distal tubule. Management: Check calcium; marked hypercalcemia suggests hidden hyperparathyroidism.
- Hyperuricemia and gout
- Volume contraction increases uric acid reabsorption, and thiazides compete with urate for secretion. Management: Use the lowest dose; caution in patients with gout.
- Hyperglycemia and lipid rise
- Hypokalemia reduces insulin release; lipid effects are dose related. Management: Monitor glucose and lipids; adjust diabetes drugs.
- Sulfonamide hypersensitivity and angle-closure glaucoma
- HCTZ is a sulfonamide; the eye reaction is idiosyncratic. Management: Avoid in sulfonamide allergy; stop at once for eye pain or vision loss.